Actinium Pharmaceuticals shares owned by UBS Group
Quarter-by-quarter ownership of Actinium Pharmaceuticals (ATNM) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Actinium Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Actinium Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Actinium Pharmaceuticals by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $23k | 15k | 1.60 |
| 2025-06-30 | $36k | 26k | 1.40 |
| 2025-03-31 | $638k | 396k | 1.61 |
| 2024-12-31 | $112k | 89k | 1.26 |
| 2024-09-30 | $70k | 37k | 1.88 |
| 2024-06-30 | $169k | 23k | 7.40 |
| 2024-03-31 | $217k | 28k | 7.83 |
| 2023-12-31 | $151k | 30k | 5.08 |
| 2023-09-30 | $72k | 12k | 5.92 |
| 2023-03-31 | $26k | 2.7k | 9.45 |
| 2022-12-31 | $35k | 3.2k | 10.65 |
| 2022-09-30 | $0 | 1.8k | 0.00 |
| 2022-06-30 | $0 | 36 | 0.00 |
| 2021-12-31 | $0 | 50 | 0.00 |
| 2021-09-30 | $1.0k | 150 | 6.67 |
| 2021-06-30 | $19k | 2.8k | 6.67 |
| 2021-03-31 | $1.0k | 150 | 6.67 |